Hi-Tech's DMAA Argument Dismissed: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Executive Summary
Hi-Tech gets no reconsideration; CPSC considers regulatory costs; That's It Nutrition gets cash; recalls; and more news in brief.
You may also be interested in...
Probiotics Space Ripe For M&A, Kline Analyst Says
Clorox and Reckitt Benckiser are among firms that have acquired their way into the probiotics game in recent years, and such deals are likely to continue in a space populous with niche brands.
Hi-Tech DMAA Ruling, Recalls: Health And Wellness Industry News
HiTech Pharmaceuticals will appeal ruling dismissing its complaint against FDA's seizure of its DMAA supplements; and Butala Emporium's Baidyanath brand products and McShare's Premark HS Vitamin RDA Premix are among recent recalls in the dietary supplement sector.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.